159 related articles for article (PubMed ID: 26413422)
1. Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.
Davuluri G; Schiemann WP; Plow EF; Sossey-Alaoui K
JAKSTAT; 2014; 3(4):e1009276. PubMed ID: 26413422
[TBL] [Abstract][Full Text] [Related]
2. The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer.
Bledzka K; Schiemann B; Schiemann WP; Fox P; Plow EF; Sossey-Alaoui K
Oncotarget; 2017 Nov; 8(61):104072-104089. PubMed ID: 29262622
[TBL] [Abstract][Full Text] [Related]
3. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer.
Wang W; Rana PS; Markovic V; Sossey-Alaoui K
Breast Cancer Res; 2023 Mar; 25(1):31. PubMed ID: 36949468
[TBL] [Abstract][Full Text] [Related]
4. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.
Kulkarni S; Augoff K; Rivera L; McCue B; Khoury T; Groman A; Zhang L; Tian L; Sossey-Alaoui K
PLoS One; 2012; 7(8):e42895. PubMed ID: 22952619
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the molecular signaling pathways of WAVE3.
Kansakar U; Wang W; Markovic V; Sossey-Alaoui K
Ann Transl Med; 2020 Jul; 8(14):900. PubMed ID: 32793744
[TBL] [Abstract][Full Text] [Related]
6. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
7. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the proline-rich domain of WAVE3 drives its oncogenic activity in breast cancer.
Kansakar U; Wang W; Markovic V; Sossey-Alaoui K
Sci Rep; 2021 Feb; 11(1):3868. PubMed ID: 33594155
[TBL] [Abstract][Full Text] [Related]
9. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
10. P4HA1 is a new regulator of the HIF-1 pathway in breast cancer.
Xu R
Cell Stress; 2019 Jan; 3(1):27-28. PubMed ID: 31225497
[TBL] [Abstract][Full Text] [Related]
11. The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer.
Cheng FY; Chan CH; Wang BJ; Yeh YL; Wang YJ; Chiu HW
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546453
[TBL] [Abstract][Full Text] [Related]
12. WAVE3 phosphorylation regulates the interplay between PI3K, TGF-β, and EGF signaling pathways in breast cancer.
Wang W; Kansakar U; Markovic V; Wang B; Sossey-Alaoui K
Oncogenesis; 2020 Oct; 9(10):87. PubMed ID: 33012785
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia.
Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ
Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528
[TBL] [Abstract][Full Text] [Related]
14. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway.
Wu H; Chu Y; Sun S; Li G; Xu S; Zhang X; Jiang Y; Gao S; Wang Q; Zhang J; Pang D
Front Cell Dev Biol; 2021; 9():607142. PubMed ID: 33708767
[TBL] [Abstract][Full Text] [Related]
16. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
17. Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells
Cecil DL; Slota M; O'Meara MM; Curtis BC; Gad E; Dang Y; Herendeen D; Rastetter L; Disis ML
Clin Cancer Res; 2017 Jul; 23(13):3396-3404. PubMed ID: 28039264
[No Abstract] [Full Text] [Related]
18. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells.
Sossey-Alaoui K; Safina A; Li X; Vaughan MM; Hicks DG; Bakin AV; Cowell JK
Am J Pathol; 2007 Jun; 170(6):2112-21. PubMed ID: 17525277
[TBL] [Abstract][Full Text] [Related]
19. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
